XML 23 R11.htm IDEA: XBRL DOCUMENT
v3.20.2

Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2020
Equity [Abstract] |
Stockholders' Equity | 4. Stockholders' Equity Common Stock See Note 1 for activities that affected common stock during the three and nine months ended September 30, 2020. At the Annual Meeting of our Company held on September 29, 2020, stockholders approved a proposal to increase the number of authorized common stock to 25,000,000 shares. Accordingly, on November 5, 2020, we filed an amendment to the Neonode Inc. Restated Certificate of Incorporation, as amended (our "Certificate of Incorporation"), with the Secretary of State of the State of Delaware to increase to 25,000,000 the number of authorized shares of our common stock. Preferred Stock On August 6, 2020, in connection with the closing of the Private Placement, the Company designated (i) 365 shares of its authorized and unissued preferred stock as Series C-1 Preferred Stock by filing a Series C-1 Certificate of Designation of Preferences, Rights and Limitations with the Secretary of State of the State of Delaware and (ii) 4,084 shares of its authorized and unissued preferred stock as Series C-2 Preferred Stock by filing a Series C-2 Certificate of Designation of Preferences, Rights and Limitations with the Secretary of State of the State of Delaware. The Series C-1 Preferred Stock and Series C-2 Preferred Stock (together, the "Preferred Shares") were converted into 684,378 shares of Neonode common stock. As of September 30, 2020, our Certificate of Incorporation authorized Series A Preferred Stock, Series B Preferred Stock, Series C-1 Preferred Stock, and Series C-2 Preferred Stock. During the year ended December 31, 2019, the only shares of our preferred stock issued and outstanding were Series B Preferred Stock. Effective July 1, 2019, all outstanding shares of our Series B Preferred Stock were converted into shares of our common stock. The holders of the Preferred Shares were entitled to receive dividends at the rate per share of 5% per annum, totaling $33,000. As of September 30, 2020, $2,000 of preferred dividends had been paid and $31,000 was accrued. No shares of preferred stock were issued and outstanding as of September 30, 2020. Details of the preferred stock activities are set forth below:
|  | Series B Preferred Stock Shares Issued |  |  | Series B Preferred Stock Amount |  |  | Series C-1 Preferred Stock Shares Issued |  |  | Series C-1 Preferred Stock Amount |  |  | Series C-2 Preferred Stock Shares Issued |  |  | Series C-2 Preferred Stock Amount |
Balances, December 31, 2018 |  |  | 82 |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Balances, March 31, 2019 |  |  | 82 |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Conversion of Series B Preferred Stock to common stock |  |  | (2 | ) |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Balances, June 30, 2019 |  |  | 80 |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Conversion of Series B Preferred Stock to common stock |  |  | (80 | ) |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Balances, September 30, 2019 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Balances, December 31, 2019 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Balances, March 31, 2020 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Balances, June 30, 2020 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Issuance of Preferred Shares for cash |  |  | - |  |  | $ | - |  |  |  | 365 |  |  | $ | 365 |  |  |  | 3,567 |  |  | $ | 3,567 |
Series C-2 Preferred Stock issued for repayment of short-term borrowings and accrued interest |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 517 |  |  |  | 517 |
Conversion of Preferred Shares to common stock |  |  | - |  |  | $ | - |  |  |  | (365 | ) |  | $ | (365 | ) |  |  | (4,084 | ) |  | $ | (4,084 | )
Balances, September 30, 2020 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Warrants As of September 30, 2020 and December 31, 2019, the Company had 431,368 warrants to purchase common stock outstanding.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration